Golden Bifid Combined with Smecta in Treatment of the Hepatogenous Diarrhea: a Report of 33 Cases / 现代生物医学进展
Progress in Modern Biomedicine
;
(24): 251-252, 2007.
Article
Dans Chinois
| WPRIM
| ID: wpr-737061
ABSTRACT
Objective:
To explore the therapeutic effect of Golden bifid combined with smecta for the patients with hepatogenous diarrhea (HD).Methods:
66 patients with HD were randomly divided into treatment group (n=33) and control group (n=33).On the basis of protecting the liver and the complex treatment, the treatment group was given Golden bifid (2.0g,three times a day) combined with smecta (3.0g,three times a day), and the control group was given levofloxacin (0.2g, twice a stools. the total efficiency (remarkable effect and effective) of two groups was calculated.Results:
The total effective rate of treatment group was 90.9%, while that of the control group was 48.5%. There were statistically significant differences between the two groups (x2=14.19,P<0.01).Conclusion:
The clinical therapeutic effect of Golden bifid combined with smecta for the patients with hepatogenous diarrhea is remarkable,which is worth spreading in the clinical application.
Texte intégral:
Disponible
Indice:
WPRIM (Pacifique occidental)
langue:
Chinois
Texte intégral:
Progress in Modern Biomedicine
Année:
2007
Type:
Article
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS